top of page

Home > Specialists > Obstetrics and Gynecology > Dr. Jun Ma (马骏)

Dr. Shijing Deng - Ophthalmologist - Beijing Tongren Hospital Beijing

Specialty & Clinical Focus:

Obstetrics and gynecology specialist and Chief Physician at Shanghai Renji Hospital in Shanghai, with a clinical focus on gynecologic oncology, epithelial ovarian cancer, fallopian tube carcinoma, benign gynecological conditions, and minimally invasive gynecologic surgery including laparoendoscopic single-site surgery (LESS).

Professional Title & Qualifications:

  • Chief Physician

Hospital & Department:

Shanghai Renji Hospital, Jiao Tong University – Department of Obstetrics and Gynecology

(address: No. 160 Pujian Road, Pudong New Area, Shanghai, 200127)

Dr. Jun Ma (马骏) - Obstetrics and Gynecology Specialist

Personal Biography

Dr. Jun Ma is a Chief Physician in the Department of Obstetrics and Gynecology at Shanghai Renji Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. His clinical work covers benign and malignant gynecological conditions, with particular interests in gynecologic oncology, epithelial ovarian cancer, fallopian tube carcinoma, and minimally invasive gynecologic surgery, including laparoendoscopic single-site surgery (LESS). His research examines artificial intelligence, biomarkers, and surgical-outcome prediction in gynecologic care.

Why Choose Dr. Jun Ma for Gynecologic Oncology and Minimally Invasive Surgery?

Dr. Jun Ma is a Chief Physician in the Department of Obstetrics and Gynecology at Shanghai Renji Hospital. His clinical focus spans benign and malignant gynecological conditions, with particular expertise in gynecologic oncology, epithelial ovarian cancer, fallopian tube carcinoma, and minimally invasive gynecologic surgery, including Laparoendoscopic Single-Site Surgery (LESS). International patients seeking a specialist opinion before medical travel to China may consider Dr. Ma when their case falls within these clinical areas.


A structured pre-travel specialist review can be particularly useful when a case involves pathology reports, imaging, previous surgery, prior treatment records, or questions about possible surgical pathways. Dr. Ma’s research on biomarkers, artificial intelligence, and surgical-outcome prediction also reflects a data-informed approach to complex gynecologic care. Preparing a concise medical summary, relevant reports, and a focused question list can help make the specialist review more productive and clarify what information may be required for the next step.

Pre-Travel Case Review & Specialist Liaison

Before arranging medical travel to Shanghai, international patients can request MedBridgeNZ coordination for a pre-travel specialist review with Dr. Jun Ma. We help organize medical-record preparation, translation coordination, a focused question list, client-authorized document transfer, and appointment communication with Shanghai Renji Hospital.


Once the hospital has accepted and scheduled the review, Dr. Ma will review the submitted records and provide his specialist opinion, recommendations, and responses to the patient’s questions. This process can help clarify whether his clinical focus is relevant to the case, what additional documentation may be required, and what administrative or travel steps should be prepared before an in-person hospital pathway is pursued.

Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.

Secure a Remote Case Review with

Dr. Jun Ma

Areas of Expertise

  • Gynecologic Oncology

  • Epithelial Ovarian Cancer

  • Peritoneal Metastasis

  • Fallopian Tube Carcinoma

  • Benign Gynecological Diseases

  • Minimally Invasive Gynecologic Surgery

  • Laparoendoscopic Single-Site Surgery (LESS)

Verified Client Satisfaction Metrics

⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating

* Treatment Pathway Satisfaction:

5.0/5.0

* Communication & Professionalism:

5.0/5.0

* High demand: Chosen online for specialist liaison and case reviews by over:

1,100 clients

(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)

Work Experience

  • Currently serves as a Chief Physician at the Department of Obstetrics and Gynecology, Renji Hospital, Shanghai Jiao Tong University School of Medicine.

Education & Training

Awards & Honors

Academic & Professional Memberships

Research & Publications

  • Investigating prognostic factors and biomarkers for epithelial ovarian cancer (EOC), such as plasma fibrinogen and neutrophil-lymphocyte ratio (F-NLR).

  • Developing prediction models using machine learning and artificial intelligence to assess surgical outcomes and prognosis in gynecologic patients.

  • Analyzing the learning curve and application of laparoendoscopic single-site surgery (LESS) for benign gynecological diseases.

  • Exploring the molecular mechanisms of ovarian cancer progression, including the role of reactive oxygen species (ROS) and tumor-associated macrophages (TAMs).

  • Case studies and literature reviews on rare conditions, such as primary neuroendocrine carcinoma of the fallopian tube.

Selected Peer-Reviewed Publications

  • Ma J, et al. Artificial Intelligence Based on Blood Biomarkers Including CTCs Predicts Outcomes in Epithelial Ovarian Cancer: A Prospective Study. Onco Targets Ther. 2021;14:3267–3280. PMID: 34040391

  • Ma J, et al. Exosomes released from PD-L1+ tumor-associated macrophages promote peritoneal metastasis of epithelial ovarian cancer by up-regulating T-cell lipid metabolism. Biochem Biophys Rep. 2023;36:101542. PMID: 37822876

  • Ma J, et al. The Learning Curve of Laparoendoscopic Single-Site Surgery in Benign Gynecological Diseases. J Invest Surg. 2022;35(2):363–370. PMID: 33395538

*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.

Frequently Asked Questions (FAQs)

Is Dr. Ma’s clinical focus relevant to my gynecological condition?


Dr. Ma’s clinical focus includes benign gynecological diseases, gynecologic oncology, epithelial ovarian cancer, fallopian tube carcinoma, and minimally invasive gynecologic surgery, including Laparoendoscopic Single-Site Surgery (LESS). The most reliable way to determine whether this expertise is relevant to your case is through a specialist review of your diagnosis, imaging, pathology, prior treatment history, and current questions. MedBridgeNZ can coordinate record preparation, translation, client-authorized document transfer, and appointment communication with Shanghai Renji Hospital. Once the review is accepted and scheduled, Dr. Ma will review the submitted materials and provide his specialist opinion.


How can I request a remote specialist review with Dr. Ma before traveling to Shanghai?


International patients can request MedBridgeNZ coordination for a remote specialist review with Dr. Ma before making travel arrangements. We help organize the medical summary, relevant reports, imaging or pathology files, translation coordination, a focused question list, client-authorized document transfer, and appointment communication with Shanghai Renji Hospital. Once the review is accepted and scheduled, Dr. Ma will review the submitted records, provide his opinion and recommendations, and respond to the patient’s questions. The resulting information can help the patient prepare for possible next steps and decide whether to explore an in-person hospital pathway in Shanghai.


What support is available if I travel to Shanghai for hospital care?


If an in-person pathway is pursued, MedBridgeNZ can assist with appointment request coordination, medical invitation or visa-document coordination support, travel planning, accommodation coordination, translation arrangements, and non-clinical bilingual administrative support during hospital visits. Dr. Ma and the clinical team at Shanghai Renji Hospital remain responsible for medical evaluation, treatment planning, and any procedure performed. MedBridgeNZ’s role is to help organize the practical steps around the hospital pathway so that international patients and accompanying family members can navigate the process more clearly.

Flexible Ways to Connect with the Specialist

We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:

  • Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.

  • On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.

  • In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.

How MedBridgeNZ Helps You:

MedBridgeNZ is a New Zealand–based medical concierge and logistics coordination provider for international patients exploring specialist-care pathways in China. We assist with appointment request coordination, medical-record preparation, translation coordination, client-authorized document transfer, medical invitation or visa-document coordination support, travel planning, accommodation coordination, and non-clinical bilingual administrative support. MedBridgeNZ does not provide medical advice, diagnosis, or treatment. Hospital, specialist, diagnostic, treatment, and travel charges are paid separately to the relevant third-party providers unless expressly stated otherwise in writing.

bottom of page